Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
22%
OVERLAP
BY WEIGHT
3
# OF OVERLAPPING
HOLDINGS
OZEM
21
HOLDINGS
14%
ALSO IN PPH
PPH
27
HOLDINGS
13%
ALSO IN OZEM
SECTOR DRIFT (OZEM minus PPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in OZEM |
Weight in PPH |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 12.3% | 18.8% | 12.3% |
|
PFIZER INC | 7.6% | 5.2% | 5.2% |
 |
NOVO-NORDISK A/S-SPONS ADR | 12.1% | 4.8% | 4.8% |
OZEM Overweight Relative to PPH
|
NOVO-NORDISK A/S-SPONS ADR | 7.3% |
 |
CHINA PHARMACEUTICAL GROUP | 6.9% |
|
VIKING THERAPEUTICS, INC. | 5.0% |
 |
HANMI PHARM CO LTD | 4.8% |
|
AMGEN INC | 4.2% |
 |
ASCLETIS PHARMA, INC. | 4.1% |
|
KAILERA THERAPEUTICS INC | 4.1% |
 |
CHUGAI PHARMACEUTICAL CO LTD | 4.0% |
|
ZEALAND PHARMA A/S | 4.0% |
 |
ASTRAZENECA PLC | 3.3% |
OZEM Underweight Relative to PPH
|
MERCK & CO. INC. | -11.0% |
 |
NOVARTIS AG-ADR | -9.3% |
|
ELI LILLY & CO | -6.6% |
|
BRISTOL-MYERS SQUIBB CO | -4.9% |
|
MCKESSON CORP | -4.8% |
|
ABBVIE INC | -4.7% |
|
JOHNSON & JOHNSON | -4.6% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -4.1% |
 |
SANOFI-AVENTIS-ADR | -4.0% |
|
CENCORA INC | -3.8% |